Global Hodgkin's Lymphoma Radiation Therapies and Epidemiology - 2016

  • ID: 3691944
  • Report
  • Region: Global
  • 110 pages
  • Epipatients
1 of 3
The latest survey Global Hodgkin's Lymphoma Radiation Therapies and Epidemiology – 2016, provides insights into total Hodgkin's Lymphoma patients on radiation therapies in top 7 markets, Hodgkin's Lymphoma treatable patients, and Hodgkin's Lymphoma epidemiology in top 7 markets. Epipatients conducted an online survey with Hodgkin's Lymphoma specialists, oncologists, and Hodgkin's Lymphoma patients to identify the Hodgkin's Lymphoma patients in top 7 markets who were treated by radiation therapies. The research also identifies total Hodgkin's Lymphoma patients’ on radiation therapies by Hodgkin's Lymphoma stages.
Hodgkin's Lymphoma patients undergo radiation therapy (Involved site radiation, Involved field radiation, Extended field radiation, Total body irradiation) as a part of their treatment. This study accurately determines and forecast Hodgkin's Lymphoma patients who were on radiation therapies in a given year. This research also provides insights into Hodgkin's Lymphoma epidemiology including Hodgkin's Lymphoma incidence and Hodgkin's Lymphoma prevalence by Hodgkin's Lymphoma stages I-IV.

Key Questions Answered:
- Countries: US, Japan, Germany, France, Italy, Spain, UK
- Hodgkin's Lymphoma Incidence in top 7 markets by staging – Stage I, Stage II, Stage III, and Stage IV
- Hodgkin's Lymphoma Prevalence in top 7 markets (10-year) by staging – Stage I, Stage II, Stage III, and Stage IV
- Hodgkin's Lymphoma Treatable Patients in top 7 markets by staging – Stage I, Stage II, Stage III, and Stage IV
- Hodgkin's Lymphoma Patients on radiation therapies by stages – Stage I, Stage II, Stage III, and Stage IV
- Base Year – 2015, Historic from 2010 and forecast to 2025

Key Benefits:
This research will help analysts, healthcare providers, pharmaceutical companies, epidemiologists, clinical research organizations, universities, government agencies, and insurers to determine their study population. This research will help executives estimate Hodgkin's Lymphoma market potential, Hodgkin's Lymphoma radiation therapies market potential, assess unmet need, patient share, market share, develop forecasting models, and build patient-based health management frameworks. The data presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Methodology
2. Hodgkin's Lymphoma Patients Globally by Stages
2.1. Incidence
2.2. Prevalence
2.3. Treatable Patients
2.4. Patients on Radiation Therapies
3. Hodgkin's Lymphoma Patients in Germany by Stages
3.1. Incidence
3.2. Prevalence
3.3. Treatable Patients
3.4. Patients on Radiation Therapies
4. Hodgkin's Lymphoma Patients in France by Stages
4.1. Incidence
4.2. Prevalence
4.3. Treatable Patients
4.4. Patients on Radiation Therapies
5. Hodgkin's Lymphoma Patients in Italy by Stages
5.1. Incidence
5.2. Prevalence
5.3. Treatable Patients
5.4. Patients on Radiation Therapies
6. Hodgkin's Lymphoma Patients in Spain by Stages
6.1. Incidence
6.2. Prevalence
6.3. Treatable Patients
6.4. Patients on Radiation Therapies
7. Hodgkin's Lymphoma Patients in UK by Stages
7.1. Incidence
7.2. Prevalence
7.3. Treatable Patients
7.4. Patients on Radiation Therapies
8. Hodgkin's Lymphoma Patients in Japan by Stages
8.1. Incidence
8.2. Prevalence
8.3. Treatable Patients
8.4. Patients on Radiation Therapies
9. Hodgkin's Lymphoma Patients in US by Stages
9.1. Incidence
9.2. Prevalence
9.3. Treatable Patients
9.4. Patients on Radiation Therapies
10. Glossary

1. Hodgkin's Lymphoma Incidence by Stages, Global, 2010 - 2025
2. Hodgkin's Lymphoma Prevalence by Stages, Global, 2010 - 2025
3. Hodgkin's Lymphoma Treatable Patients by Stages, Global, 2010 - 2025
4. Total Hodgkin's Lymphoma Patients on Radiation Therapies by Stages, Global, 2010 – 2025
5. Hodgkin's Lymphoma Incidence by Stages, Germany, 2010 - 2025
6. Hodgkin's Lymphoma Prevalence by Stages, Germany, 2010 - 2025
7. Hodgkin's Lymphoma Treatable Patients by Stages, Germany, 2010 - 2025
8. Total Hodgkin's Lymphoma Patients on Radiation Therapies by Stages, Germany, 2010 - 2025
9. Hodgkin's Lymphoma Incidence by Stages, France, 2010 - 2025
10. Hodgkin's Lymphoma Prevalence by Stages, France, 2010 - 2025
11. Hodgkin's Lymphoma Treatable Patients by Stages, France, 2010 - 2025
12. Total Hodgkin's Lymphoma Patients on Radiation Therapies by Stages, France, 2010 - 2025
13. Hodgkin's Lymphoma Incidence by Stages, Italy, 2010 - 2025
14. Hodgkin's Lymphoma Prevalence by Stages, Italy, 2010 - 2025
15. Hodgkin's Lymphoma Treatable Patients by Stages, Italy, 2010 - 2025
16. Total Hodgkin's Lymphoma Patients on Radiation Therapies by Stages, Italy, 2010 - 2025
17. Hodgkin's Lymphoma Incidence by Stages, Spain, 2010 - 2025
18. Hodgkin's Lymphoma Prevalence by Stages, Spain, 2010 - 2025
19. Hodgkin's Lymphoma Treatable Patients by Stages, Spain, 2010 - 2025
20. Total Hodgkin's Lymphoma Patients on Radiation Therapies by Stages, Spain, 2010 - 2025
21. Hodgkin's Lymphoma Incidence by Stages, UK, 2010 - 2025
22. Hodgkin's Lymphoma Prevalence by Stages, UK, 2010 - 2025
23. Hodgkin's Lymphoma Treatable Patients by Stages, UK, 2010 - 2025
24. Total Hodgkin's Lymphoma Patients on Radiation Therapies by Stages, UK, 2010 – 2025
25. Hodgkin's Lymphoma Incidence by Stages, Japan, 2010 - 2025
26. Hodgkin's Lymphoma Prevalence by Stages, Japan, 2010 - 2025
27. Hodgkin's Lymphoma Treatable Patients by Stages, Japan, 2010 - 2025
28. Total Hodgkin's Lymphoma Patients on Radiation Therapies by Stages, Japan, 2010 – 2025
29. Hodgkin's Lymphoma Incidence by Stages, US, 2010 - 2025
30. Hodgkin's Lymphoma Prevalence by Stages, US, 2010 - 2025
31. Hodgkin's Lymphoma Treatable Patients by Stages, US 2010 - 2025
32. Total Hodgkin's Lymphoma Patients on Radiation Therapies by Stages, US, 2010 - 2025

1. Hodgkin's Lymphoma Incidence, Global, 2010 – 2025
2. Hodgkin's Lymphoma Incidence – Stage I, Global, 2010 – 2025
3. Hodgkin's Lymphoma Incidence – Stage II, Global, 2010 - 2025
4. Hodgkin's Lymphoma Incidence – Stage III, Global, 2010 - 2025
5. Hodgkin's Lymphoma Incidence – Stage IV, Global, 2010 – 2025
6. Hodgkin's Lymphoma Prevalence, Global, 2010 - 2025
7. Hodgkin's Lymphoma Prevalence – Stage I, Global, 2010 – 2025
8. Hodgkin's Lymphoma Prevalence – Stage II, Global, 2010 - 2025
9. Hodgkin's Lymphoma Prevalence – Stage III, Global, 2010 - 2025
10. Hodgkin's Lymphoma Prevalence – Stage IV, Global, 2010 - 2025
11. Hodgkin's Lymphoma Treatable Patients, Global, 2010 - 2025
12. Hodgkin's Lymphoma Treatable Patients – Stage I, Global, 2010 – 2025
13. Hodgkin's Lymphoma Treatable Patients – Stage II, Global, 2010 - 2025
14. Hodgkin's Lymphoma Treatable Patients – Stage III, Global, 2010 - 2025
15. Hodgkin's Lymphoma Treatable Patients – Stage IV, Global, 2010 - 2025
16. Hodgkin's Lymphoma Patients on Radiation Therapies, Global, 2010 - 2025
17. Total Hodgkin's Lymphoma Patients on Radiation Therapies – Stage I, Global, 2010 – 2025
18. Total Hodgkin's Lymphoma Patients on Radiation Therapies – Stage II, Global, 2010 – 2025
19. Total Hodgkin's Lymphoma Patients on Radiation Therapies – Stage III, Global, 2010 – 2025
20. Total Hodgkin's Lymphoma Patients on Radiation Therapies – Stage IV, Global, 2010 – 2025
21. Hodgkin's Lymphoma Incidence by Stages, Germany, 2010 – 2025
22. Hodgkin's Lymphoma Prevalence by Stages, Germany, 2010 – 2025
23. Hodgkin's Lymphoma Treatable Patients by Stages, Germany, 2010 – 2025
24. Hodgkin's Lymphoma Patients on Radiation Therapies, Germany, 2010 - 2015
25. Hodgkin's Lymphoma Incidence by Stages, France, 2010 – 2025
26. Hodgkin's Lymphoma Prevalence by Stages, France, 2010 – 2025
27. Hodgkin's Lymphoma Treatable Patients by Stages, France, 2010 – 2025
28. Hodgkin's Lymphoma Patients on Radiation Therapies, France, 2010 – 2025
29. Hodgkin's Lymphoma Incidence by Stages, Italy, 2010 – 2025
30. Hodgkin's Lymphoma Prevalence by Stages, Italy, 2010 – 2025
31. Hodgkin's Lymphoma Treatable Patients by Stages, Italy, 2010 – 2025
32. Hodgkin's Lymphoma Patients on Radiation Therapies, Italy, 2010 – 2025
33. Hodgkin's Lymphoma Incidence by Stages, Spain, 2010 – 2025
34. Hodgkin's Lymphoma Prevalence by Stages, Spain, 2010 – 2025
35. Hodgkin's Lymphoma Treatable Patients by Stages, Spain, 2010 – 2025
36. Hodgkin's Lymphoma Patients on Radiation Therapies, Spain, 2010 - 2015
37. Hodgkin's Lymphoma Incidence by Stages, UK, 2010 – 2025
38. Hodgkin's Lymphoma Prevalence by Stages, UK, 2010 – 2025
39. Hodgkin's Lymphoma Treatable Patients by Stages, UK, 2010 – 2025
40. Hodgkin's Lymphoma Patients on Radiation Therapies, UK, 2010 – 2025
41. Hodgkin's Lymphoma Incidence by Stages, Japan, 2010 – 2025
42. Hodgkin's Lymphoma Prevalence by Stages, Japan, 2010 – 2025
43. Hodgkin's Lymphoma Treatable Patients by Stages, Japan, 2010 – 2025
44. Hodgkin's Lymphoma Patients on Radiation Therapies, Japan, 2010 – 2025
45. Hodgkin's Lymphoma Incidence by Stages, US, 2010 – 2025
46. Hodgkin's Lymphoma Prevalence by Stages, US, 2010 – 2025
47. Hodgkin's Lymphoma Treatable Patients by Stages, US, 2010 – 2025
48. Hodgkin's Lymphoma Patients on Radiation Therapies, US, 2010 - 2015
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll